News
Merck & Co., Inc. (NYSE:MRK) is one of the 10 best defensive stocks to buy in a volatile market. On July 2, UBS reiterated a ...
He stated that the episode of the last six months showed just how brutally efficient the price discovery process is, in any ...
Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed ...
Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...
1d
Money Talks News on MSNDemand Answers: Why Your Vaccine Costs May Skyrocket Under RFK Jr.Your free flu shots and other routine vaccines may soon come with a price tag under RFK Jr.'s leadership.
The S&P 500 fell 0.1% on Tuesday, July 8, 2025, after President Trump extended the deadline for "reciprocal" tariffs and ...
1d
Stockhead on MSNScott Power: ASX health falls as Trump revives pharma import tariff threat; CSL ‘undervalued’ASX health stocks fall o.92% over past five days as US President Donald Trump renews threat to impose tariffs on pharmaceutical imports.
Key Points Canopy Growth seems unable to overcome the industrywide challenges it faces.Novavax's recent quarterly update, though strong, says little about its prospects. 10 stocks we like better than ...
Record low results for an island health check have pushed government health leaders to urge the public to participate. The ...
Tonix Pharmaceuticals (TNXP) stock gains as the company posts peer-reviewed data for pain drug TNX-102 and new data for mpox ...
Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results